By Monica E. Oss The use of “psychedelics” to treat mental disorders seems to be on the increase—or at least the coverage of psychedelics is on the increase. The image of psychedelics has been reformed from “dangerous drugs from the 1960s counter culture” to compounds with legitimate medicinal value (see A Psychedelic Drug Boom In Mental Health Treatment Comes Closer To Reality and How Ecstasy And Psilocybin Are Shaking Up Psychiatry). We are seeing increasing consumer interest in using psychedelics—compounds like psilocybin, lysergic acid diethylamide (LSD), 3,4-methylenedioxymethamphetamine (MDMA), and ketamine (see More People Are Microdosing Psychedelic Drugs To Cope With Pandemic: Survey). The interest…
Content Restricted

This article is reserved for members with an active membership. Please register for a Free Membership to view this resource.

Login to access The OPEN MINDS Circle Library. Not a member? Create your free account now!